Effect of Ketogenic Diet on Selected Cardiometabolic-Related Diseases
DOI:
https://doi.org/10.47419/bjbabs.v6i02.287Keywords:
Ketogenic Diet, Type 2 Diabetes Mellitus , Cardiometabolic DiseaseAbstract
Cardiometabolic diseases (CMDs) are a group of metabolic abnormalities that increase the risk of diseases such as type 2 diabetes, cardiovascular diseases, insulin resistance, non-alcoholic fatty liver disease (NAFLD), dyslipidemia, and abdominal obesity. The study of CMDs’ comorbidity is an emerging field. In the quest to reduce the cost and side effects of drugs, fasting therapies like the ketogenic diet (KD) have been proposed for treating seizure disorders, cancer, and chronic diseases. Recently, it has been reported to improve the quality of life of patients with cardiometabolic-related diseases. KD is a very low-carbohydrate, high-protein, very high-fat diet that induces ketogenesis, eliciting molecular signals. Intake of KD produces inhibition of histone deacetylase and 3-hydroxy-3-methyl glutaryl coA (HMG-CoA) reductase. It also increases the particulate size of low density lipoprotein cholesterol (LDL-C), lipolysis, HMG-CoA synthase 2, cataplerotic activity, high-density lipoprotein, and sirtuin production, which results in improved health status for patients with NAFLD, diabetes, and cardiovascular diseases when KD is consumed for a minimum of two weeks. There are usually mild side effects that are experienced with this therapy, but these can be overcome after four (4) weeks of continuous intake of KD and with certain interventions like vitamins, minerals, and calcium. There is, therefore, a need to explore ways of incorporating KD into the clinical management and treatment of cardiometabolic diseases globally.
Downloads
References
Tapsell LC, Neale EP, Satija A, Hu FB. Foods, nutrients, and dietary patterns: interconnections and implications for dietary guidelines. Advances in Nutrition. 2016;7(3):445–454. 10.3945/an.115.011718. DOI: https://doi.org/10.3945/an.115.011718
Toprak İ, Güler H, Genç AS, Erbaş O. Effects of Ketone Bodies on the Brain. Journal of Experimental and Basic Medical Sciences. 2022;3(2):97–102. 10.5606/jebms.2022.1015.
Kwon HE, Kim HD. Recent aspects of ketogenic diet in neurological disorders. Acta Epileptologica. 2021;3(21). 10.1186/s42494-021-00053-1. DOI: https://doi.org/10.1186/s42494-021-00053-1
Wheless JW. History of the ketogenic diet. Epilepsia. 2008;49:3–5. 10.1111/j.1528- 1167.2008.01821.x. DOI: https://doi.org/10.1111/j.1528-1167.2008.01821.x
Kayode OT, Rotimi DE, Afolayan OA, Kayode AA. Ketogenic diet: A Nutritional remedy for some metabolic disorders. Journal of Education Health and Sport. 2020;10(8):2391–8306. 10.12775/JEHS.2020.10.08.021. DOI: https://doi.org/10.12775/JEHS.2020.10.08.021
Zhu H, Dexi BD, Youhua ZY, Cheng KC, Jiahao DJ, Xiawei WX, et al. Keto- genic diet for human diseases: the underlying mechanisms and potential for clin- ical implementations. Signal Transduction and Targeted Therapy. 2022;7(1):11–11. 10.1038/s41392-021-00831-w. DOI: https://doi.org/10.1038/s41392-021-00831-w
Longo R, Peri C, Cricrì D, Coppi L, Caruso D, Mitro N, et al. Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry. Nutrients. 2019;11(10):2497–2497. 10.3390/nu11102497. DOI: https://doi.org/10.3390/nu11102497
Ungaro P, Nettore IC, Franchini F, Palatucci G, Muscogiuri G, Colao A, et al. Epigenome Modulation Induced by Ketogenic Diets. Nutrients. 2022;14(15):3245– 3245. 10.3390/nu14153245. DOI: https://doi.org/10.3390/nu14153245
Morris G, Maes M, Berk M, Carvalho AF, Puri BK. Nutritional ketosis as an inter- vention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders. Eur Psychiatry. 2020;63(1):e8– e8. 10.1192/j.eurpsy.2019.13. DOI: https://doi.org/10.1192/j.eurpsy.2019.13
Gerhauser C. Impact of dietary gut microbial metabolites on the epigenome. Philosophical Transactions of the Royal Society B: Biological Sciences. 2018;373(1748):20170359–20170359. 10.1098/rstb.2017.0359. DOI: https://doi.org/10.1098/rstb.2017.0359
Newman JC, Verdin E. β-Hydroxybutyrate: a signaling metabolite. Annual Review. 2017;37:51–76. 10.1146/annurev-nutr-071816-064916. DOI: https://doi.org/10.1146/annurev-nutr-071816-064916
Dowis K, Banga S. The potential health benefits of the ketogenic diet: A narrative review. Nutrients. 2021;13(5):1654–1654. 10.3390/nu13051654. DOI: https://doi.org/10.3390/nu13051654
Miller VJ, Villamena FA, Volek JS. Nutritional ketosis and mitohormesis: potential implications for mitochondrial function and human health. Journal of Nutrition and Metabolism. 2018;p. 5157645–5157645. 10.1155/2018/5157645. DOI: https://doi.org/10.1155/2018/5157645
Moreno CL, Mobbs CV. Epigenetic mechanisms underlying lifespan and age- related effects of dietary restriction and the ketogenic diet. Molecular and Cellular Endocrinology. 2017;5(455):33–40. 10.1016/j.mce.2016.11.013. DOI: https://doi.org/10.1016/j.mce.2016.11.013
Muller C. Diabetes, American Chemistry Society Pharmacology & Translation Sci- ence. vol. 5 of 8; 2022. p. 513–691. DOI: https://doi.org/10.1021/acsptsci.2c00122
Caradonna F, Consiglio O, Luparello C, Gentile C. Science and healthy meals in the world: Nutritional epigenomics and nutrigenetics of the mediterranean diet. Nutri- ents. 2020;12(6):1748–1748. 10.3390/nu12061748. DOI: https://doi.org/10.3390/nu12061748
Yamada K, Takizawa S, Ohgaku Y, Asami T, Furuya K, Yamamoto K, et al. MicroRNA 16-5p is upregulated in calorie-restricted mice and modulates inflammatory cytokines of macrophages. Gene. 2020;725:144191–144191. 10.1016/j.gene.2019.144191. DOI: https://doi.org/10.1016/j.gene.2019.144191
Cannataro R, Caroleo MC, Fazio A, Torre CL, Plastina P, Gallelli L, et al. Ketogenic diet and microRNAs linked to antioxidant biochemical homeostasis. Antioxidants. 2019;8(8):269–269. 10.3390/antiox8080269. DOI: https://doi.org/10.3390/antiox8080269
Kim CW, Aronow WS, Frishman WH. Coronavirus Disease 2019 and Cardiometabolic Disease. Cardiology in Review. 2022;30(3):123–128. 10.1097/CRD.0000000000000405. DOI: https://doi.org/10.1097/CRD.0000000000000405
Dashti HM, Mathew TC, Zaid NS. Efficacy of low-carbohydrate ketogenic diet in the treatment of type 2 diabetes. Medical Principles and Practice. 2021;30(3):223–235. 10.1159/000512142. DOI: https://doi.org/10.1159/000512142
Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The preva- lence and incidence of NAFLD worldwide: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2022;7(9):851–861. 10.1016/S2468- 1253(22)00165-0. DOI: https://doi.org/10.1016/S2468-1253(22)00165-0
Paruk IM, Pirie FJ, Motala AA. Non-alcoholic fatty liver disease in Africa: a hidden danger. Global Health, Epidemiology and Genomics. 2019;4:1–4. 10.1017/gheg.2019.2. DOI: https://doi.org/10.1017/gheg.2019.2
Ezema IC, Uchenwoke GM, Ugwueze IUC, Ugueze CU, Uduonu EU, Okezue NC, et al.; 2021.
Fan JG, Kim SU, Wong VWS. New trends on obesity and NAFLD in Asia. Journal of hepatology. 2017;67(4):862–873. 10.1016/j.jhep.2017.06.003. DOI: https://doi.org/10.1016/j.jhep.2017.06.003
Sripongpun P, Chaitong C, Chalermrat BC. Current Evidence Concerning Effects of Ketogenic Diet and Intermittent Fasting in Patients with Nonalcoholic Fatty Liver. Journal of Clinical and Translational Hepatology. 2022;10(4):730–739. 10.14218/JCTH.2021.00494. DOI: https://doi.org/10.14218/JCTH.2021.00494
Alharbi A, Al-Sowayan NS. The Effect of Ketogenic-Diet on Health. Food and Nutri- tion Sciences. 2020;11(4):301–313. 10.4236/fns.2020.114022. DOI: https://doi.org/10.4236/fns.2020.114022
Long AN, Dagogo-Jack S. Comorbidities of diabetes and hypertension: mecha- nisms and approach to target organ protection. The journal of clinical hypertension. 2011;13(4):244–251. 10.1111/j.1751-7176.2011.00434.x. DOI: https://doi.org/10.1111/j.1751-7176.2011.00434.x
Leow ZX, Guelfi KJ, Davis EA, Jones TW, Fournier PA. The glycaemic benefits of a very-low-carbohydrate ketogenic diet in adults with type 1 diabetes mellitus may be opposed by increased hypoglycaemia risk and dyslipidaemia. Diabet Med. 2018;35:1258–63. 10.1111/dme.13663. DOI: https://doi.org/10.1111/dme.13663
Schneider S, Biggerstaff DL, Barber TM. Helpful or harmful? The impact of the ketogenic diet on eating disorder outcomes in type 1 diabetes mel- litus. Expert Review of Endocrinology & Metabolism. 2022;17(4):319–331. 10.1080/17446651.2022.2089112. DOI: https://doi.org/10.1080/17446651.2022.2089112
Vilar-Gomez E, Athinarayanan SJ, Adams RN, Hallberg SJ, Bhanpuri NH, Mcken- zie AL, et al. Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study. British Medical Journal. 2019;9(2):23597–23597. 10.1136/bmjopen-2018- 023597. DOI: https://doi.org/10.1136/bmjopen-2018-023597
Hall KD, Chen KY, Guo J, Lam YY, Leibel RL, Mayer LE, et al. Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese men. Am J Clin Nutr;104(2):324–333. 10.3945/ajcn.116.133561. DOI: https://doi.org/10.3945/ajcn.116.133561
Subramaniam A, Park B, Raphael D, Landstrom M, Hayes KC. Dietary Carbo- hydrate as Glycemic Load, Not Fat, Coupled with Genetic Permissiveness Favor- ing Rapid Growth and Extra Calories, Dictate Metabolic Syndrome and Diabetes Induction in Nile Rats (Arvicanthis niloticus). Nutrients. 2022;14(15):3064–3064. 10.3390/nu14153064. DOI: https://doi.org/10.3390/nu14153064
Goldenberg JZ, Day A, Brinkworth GD, Sato J, Yamada S, Jönsson T, et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: sys- tematic review and meta- analysis of published and unpublished randomized trial data. British Medical Journal. 2021;p. 372–372. 10.1136/bmj.m4743. DOI: https://doi.org/10.1136/bmj.m4743
Tinguely D, Gross J, Kosinski C. Efficacy of Ketogenic Diets on Type 2 Diabetes: a Systematic Review. Current Diabetic Reports. 2021;21(9):32–32. 10.1007/s11892- 021-01399-z. DOI: https://doi.org/10.1007/s11892-021-01399-z
Yuan X, Wang J, Yang S, Gao M, Cao L, Li X, et al. Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis. Nutrition & Diabetes. 2020;10(1):38–38. 10.1038/s41387-020-00142-z. DOI: https://doi.org/10.1038/s41387-020-00142-z
Kephart WC, Pledge CD, Roberson PA, Mumford PW, Romero MA, Mobley CB, et al. The three-month effects of a ketogenic diet on body composition, blood parameters, and performance metrics in CrossFit Trainees: a pilot study. Sports. 2018;6(1):1–1. 10.3390/sports6010001. DOI: https://doi.org/10.3390/sports6010001
Crosby L, Davis B, Joshi S, Jardine M, Paul J, Neola M, et al. Ketogenic Diets and Chronic Disease: Weighing the Benefits Against the Risks. Front Nutr . 2021;8:702802–702802. 10.3389/fnut.2021.702802. DOI: https://doi.org/10.3389/fnut.2021.702802
Selvaraj S, Kelly DP, Margulies KB. Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure. Circulation . 2020;141(22):1800–1812. 10.1161/CIRCULATIONAHA.119.045033. DOI: https://doi.org/10.1161/CIRCULATIONAHA.119.045033
Additional Files
Published
Issue
Section
Categories
License
Copyright (c) 2025 Faith Ogbonnaya, Olutayo S. Shokunbi
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain all proprietary rights, including copyright, such as patent and trademark rights and rights to any process or procedure described in the article.
